BlackRock’s Microbot Medical MBOT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.07M | Sell |
857,398
-11,254
| -1% | -$25.1K | ﹤0.01% | 4129 |
|
|
2025
Q4 | $1.74M | Buy |
868,652
+378,463
| +77% | +$897K | ﹤0.01% | 4158 |
|
|
2025
Q3 | $1.5M | Buy |
490,189
+169,007
| +53% | +$527K | ﹤0.01% | 4184 |
|
|
2025
Q2 | $809K | Buy |
321,182
+85,077
| +36% | +$204K | ﹤0.01% | 4317 |
|
|
2025
Q1 | $357K | Buy |
236,105
+98,730
| +72% | +$175K | ﹤0.01% | 4474 |
|
|
2024
Q4 | $154K | Hold |
137,375
| – | – | ﹤0.01% | 4678 |
|
|
2024
Q3 | $123K | Hold |
137,375
| – | – | ﹤0.01% | 4633 |
|
|
2024
Q2 | $140K | Hold |
137,375
| – | – | ﹤0.01% | 4619 |
|
|
2024
Q1 | $169K | Sell |
137,375
-433
| -0.3% | -$549 | ﹤0.01% | 4627 |
|
|
2023
Q4 | $226K | Hold |
137,808
| – | – | ﹤0.01% | 4606 |
|
|
2023
Q3 | $192K | Hold |
137,808
| – | – | ﹤0.01% | 4690 |
|
|
2023
Q2 | $375K | Sell |
137,808
-14,746
| -10% | -$29.5K | ﹤0.01% | 4568 |
|
|
2023
Q1 | $317K | Buy |
152,554
+474
| +0.3% | +$1.4K | ﹤0.01% | 4658 |
|
|
2022
Q4 | $458K | Buy |
152,080
+150
| +0.1% | +$622 | ﹤0.01% | 4630 |
|
|
2022
Q3 | $726K | Sell |
151,930
-395
| -0.3% | -$2.03K | ﹤0.01% | 4596 |
|
|
2022
Q2 | $782K | Sell |
152,325
-2,608
| -2% | -$14.5K | ﹤0.01% | 4632 |
|
|
2022
Q1 | $971K | Sell |
154,933
-961
| -0.6% | -$5.63K | ﹤0.01% | 4673 |
|
|
2021
Q4 | $1.17M | Buy |
155,894
+881
| +0.6% | +$5.68K | ﹤0.01% | 4617 |
|
|
2021
Q3 | $1.09M | Buy |
155,013
+16,205
| +12% | +$118K | ﹤0.01% | 4526 |
|
|
2021
Q2 | $1.1M | Sell |
138,808
-55,544
| -29% | -$420K | ﹤0.01% | 4487 |
|
|
2021
Q1 | $1.65M | Buy |
194,352
+2,551
| +1% | +$21.9K | ﹤0.01% | 4350 |
|
|
2020
Q4 | $1.32M | Buy |
191,801
+1,583
| +0.8% | +$11.9K | ﹤0.01% | 4150 |
|
|
2020
Q3 | $1.45M | Sell |
190,218
-23,924
| -11% | -$169K | ﹤0.01% | 3992 |
|
|
2020
Q2 | $1.48M | Buy |
214,142
+1,810
| +0.9% | +$12.3K | ﹤0.01% | 3918 |
|
|
2020
Q1 | $1.18M | Buy |
212,332
+29,436
| +16% | +$258K | ﹤0.01% | 3824 |
|
|
2019
Q4 | $1.86M | Sell |
182,896
-96
| -0.1% | -$563 | ﹤0.01% | 3816 |
|
|
2019
Q3 | $970K | Sell |
182,992
-528
| -0.3% | -$3.09K | ﹤0.01% | 3986 |
|
|
2019
Q2 | $945K | Buy |
183,520
+9,906
| +6% | +$65.6K | ﹤0.01% | 4026 |
|
|
2019
Q1 | $1.34M | Buy |
173,614
+168,763
| +3,479% | +$1.31M | ﹤0.01% | 3825 |
|
|
2018
Q4 | $8K | Hold |
4,851
| – | – | ﹤0.01% | 4685 |
|
|
2018
Q3 | $36K | Sell |
4,851
-2
| -0% | -$17 | ﹤0.01% | 4581 |
|
|
2018
Q2 | $54K | Buy |
4,853
+1,239
| +34% | +$15.1K | ﹤0.01% | 4548 |
|
|
2018
Q1 | $36K | Sell |
3,614
-16
| -0.4% | -$216 | ﹤0.01% | 4481 |
|
|
2017
Q4 | $55K | Hold |
3,630
| – | – | ﹤0.01% | 4422 |
|
|
2017
Q3 | $63K | Hold |
3,630
| – | – | ﹤0.01% | 4439 |
|
|
2017
Q2 | $77K | Sell |
3,630
-340
| -9% | -$18.8K | ﹤0.01% | 4450 |
|
|
2017
Q1 | $346K | Buy |
+3,970
| New | +$349K | ﹤0.01% | 4065 |
|
Other funds holding MBOT
VCM
CBU
AA
BlackRock's MBOT Position: Q1 2026 in Review
BlackRock reduced its Microbot Medical (MBOT) stake by 1.3% in Q1 2026, selling an estimated $25.1K and leaving 857,398 shares worth $2.07M. The position accounts for ﹤0.01% of the portfolio, ranked #4129.
BlackRock first reported a position in MBOT in Q1 2017 and has held it in 37 quarters since. 79 funds tracked by Wall St. Rank hold MBOT as of Q1 2026.
- BlackRock held 857,398 shares of Microbot Medical worth $2.07M as of Q1 2026.
- BlackRock sold 11,254 Microbot Medical shares in Q1 2026, an estimated $25.1K.
- Microbot Medical made up ﹤0.01% of BlackRock's portfolio in Q1 2026, its #4129 holding.
- BlackRock first reported a position in Microbot Medical in Q1 2017 and has held it in 37 quarters since.
- 79 funds tracked by Wall St. Rank held Microbot Medical as of Q1 2026.
Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.